Nicotinic acetylcholine receptors are widely distributed throughout the human brain and are believed to play a role in several neurological and psychiatric disorders. In order to identify an effective PET radioligand for in vivo assessment of the a4b2 subtype of nicotinic receptor, we synthesized [
Radiosynthesis of 2-exo-(2′-[18F]Fluoro-3′-(4-fluorophenyl)-pyridin-5′-yl)-7-azabicyclo[2.2.1]heptane ([18F]F2PhEP), a potent epibatidine-based radioligand for nicotinic acetylcholine receptor PET imaging
✍ Scribed by Gaëlle Roger; Françoise Hinnen; Héric Valette; Wadad Saba; Michel Bottlaender; Frédéric Dollé
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- French
- Weight
- 189 KB
- Volume
- 49
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
✦ Synopsis
2-exo-(2 0 -Fluoro-3 0 -(4-fluorophenyl)-pyridin-5 0 -yl)-7-azabicyclo[2.2.1]heptane (F 2 PhEP), a novel, epibatidine-based, a4b2-selective nicotinic acetylcholine receptor antagonist of low toxicity, as well as the corresponding N-Boc-protected chloro-and bromo derivatives as precursors for labelling with fluorine-18 were synthesized from 7-tertbutoxycarbonyl-7-azabicyclo[2.2.1]hept-2-ene in 13, 19 and 8% overall yield, respectively. [ 18 F]F 2 PhEP was prepared in 8-9% overall yield (non-decay-corrected) using 1 mg of the bromo derivative in the following two-step radiochemical process:
(1) no-carrier-added nucleophilic heteroaromatic ortho-radiofluorination with the activated K[ 18 F]F-Kryptofix 1 222 complex in DMSO using microwave activation at 250 W for 90 s, followed by (2) quantitative TFA-induced removal of the N-Boc protective group. Radiochemically pure (>95%) [ 18 F]F 2 PhEP (1.48-1.66 GBq, 74-148 GBq/mmol) was obtained after semi-preparative HPLC (Symmetry 1 C18, eluent aqueous 0.05 M NaH 2 PO 4 CH 3 CN: 78/22 (v:v)) in 75-80 min starting from an 18.5 GBq aliquot of a cyclotron-produced [ 18 F]fluoride production batch. Copyright
📜 SIMILAR VOLUMES
## Abstract 6‐Chloro‐3‐((2‐(__S__)‐azetidinyl)methoxy)‐5‐(2‐[^18^F]fluoropyridin‐4‐yl)pyridine ([^18^F]NIDA 522131), a potential radioligand for studying extrathalamic nicotinic acetylcholine receptors by positron‐emission tomography, was synthesized via no‐carrier‐added nucleophilic [^18^F]fluorin
## Abstract 6‐Chloro‐3‐((2‐(__S__)‐azetidinyl)methoxy)‐5‐((__E__)‐2‐(2‐[^18^F]fluoropyridin‐4‐yl)vinyl)pyridine ([^18^F]NIDA 52289), a very high affinity radioligand for studying nicotinic acetylcholine receptors (nAChRs) by positron‐emission tomography, was synthesized through Kryptofix 222 assist
## Abstract 4‐Fluoro‐__N__‐{2‐[4‐(6‐trifluoromethylpyridin‐2‐yl)piperazin‐1‐yl]ethyl}benzamide is a full 5‐HT~1A~ agonist with high affinity (__pK__~__i__~=9.3), selectivity and a __c__ log __P__ of 3.045. The corresponding PET radioligand 4‐[^18^F]fluoro‐__N__‐{2‐[4‐(6‐trifluoromethylpyridin‐2‐yl)
## Abstract The feasibility of nucleophilic displacement of bromide in the 4‐bromopyrazole ring with [^18^F]fluoride has been demonstrated by the synthesis of two radiolabeled compounds: __N__‐(piperidin‐1‐yl)‐5‐(4‐methoxyphenyl)‐1‐(2‐chlorophenyl)‐4‐[^18^F]fluoro‐1__H__‐pyrazole‐3‐carboxamide, ([^